Covid-19 Impact on Global mRNA Vaccines Market Size, Status and Forecast 2020-2026


This report focuses on the global mRNA Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
    MODERNA
    Pfizer
    Zydus Cadila
    Fosun Pharmaceutical
    CureVac
    Stemirna
    ...

Market segment by Type, the product can be split into
    Being Developed
    Preclinical
    Clinical I
    Clinical II
Market segment by Application, split into
    COVID-19
    Cancer
    Infectious Disease Treatment MRNA Vaccine
    Infection Prevention MRNA Vaccine

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global mRNA Vaccines status, future forecast, growth opportunity, key market and key players.
    To present the mRNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of mRNA Vaccines are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by mRNA Vaccines Revenue
    1.4 Market Analysis by Type
        1.4.1 Global mRNA Vaccines Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 Being Developed
        1.4.3 Preclinical
        1.4.4 Clinical I
        1.4.5 Clinical II
    1.5 Market by Application
        1.5.1 Global mRNA Vaccines Market Share by Application: 2020 VS 2026
        1.5.2 COVID-19
        1.5.3 Cancer
        1.5.4 Infectious Disease Treatment MRNA Vaccine
        1.5.5 Infection Prevention MRNA Vaccine
    1.6 Coronavirus Disease 2019 (Covid-19): mRNA Vaccines Industry Impact
        1.6.1 How the Covid-19 is Affecting the mRNA Vaccines Industry
            1.6.1.1 mRNA Vaccines Business Impact Assessment - Covid-19
            1.6.1.2 Supply Chain Challenges
            1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
        1.6.2 Market Trends and mRNA Vaccines Potential Opportunities in the COVID-19 Landscape
        1.6.3 Measures / Proposal against Covid-19
            1.6.3.1 Government Measures to Combat Covid-19 Impact
            1.6.3.2 Proposal for mRNA Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
    2.1 mRNA Vaccines Market Perspective (2015-2026)
    2.2 mRNA Vaccines Growth Trends by Regions
        2.2.1 mRNA Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 mRNA Vaccines Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
    3.1 mRNA Vaccines Revenue by Players (2019-2020)
    3.2 mRNA Vaccines Key Players Head office and Area Served
    3.3 Key Players mRNA Vaccines Product/Solution/Service
    3.4 Date of Enter into mRNA Vaccines Market
    3.5 Key Players mRNA Vaccines Funding/Investment Analysis
    3.6 Global Key Players mRNA Vaccines Valuation & Market Capitalization
    3.7 Mergers & Acquisitions, Expansion Plans

4 Global mRNA Vaccines Market Size by Type (2019-2026)

5 Global mRNA Vaccines Market Size by Application (2019-2026)

6 North America
    6.1 North America mRNA Vaccines Market Forecast (2019-2026)
    6.2 mRNA Vaccines Key Players in North America (2019-2020)
    6.3 North America mRNA Vaccines Market Size by Type (2015-2020)
    6.4 North America mRNA Vaccines Market Size by Application (2015-2020)

7 Europe
    7.1 Europe mRNA Vaccines Market Forecast (2019-2026)
    7.2 mRNA Vaccines Key Players in Europe (2019-2020)
    7.3 Europe mRNA Vaccines Market Size by Type (2015-2020)
    7.4 Europe mRNA Vaccines Market Size by Application (2015-2020)

8 China
    8.1 China mRNA Vaccines Market Forecast (2019-2026)
    8.2 mRNA Vaccines Key Players in China (2019-2020)
    8.3 China mRNA Vaccines Market Size by Type (2015-2020)
    8.4 China mRNA Vaccines Market Size by Application (2015-2020)

9 Japan
    9.1 Japan mRNA Vaccines Market Forecast (2019-2026)
    9.2 mRNA Vaccines Key Players in Japan (2019-2020)
    9.3 Japan mRNA Vaccines Market Size by Type (2015-2020)
    9.4 Japan mRNA Vaccines Market Size by Application (2015-2020)

10 Southeast Asia
    10.1 Southeast Asia mRNA Vaccines Market Forecast (2019-2026)
    10.2 mRNA Vaccines Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia mRNA Vaccines Market Size by Type (2015-2020)
    10.4 Southeast Asia mRNA Vaccines Market Size by Application (2015-2020)

11 India
    11.1 India mRNA Vaccines Market Forecast (2019-2026)
    11.2 mRNA Vaccines Key Players in India (2019-2020)
    11.3 India mRNA Vaccines Market Size by Type (2015-2020)
    11.4 India mRNA Vaccines Market Size by Application (2015-2020)

12 Central & South America
    12.1 Central & South America mRNA Vaccines Market Forecast (2019-2026)
    12.2 mRNA Vaccines Key Players in Central & South America (2019-2020)
    12.3 Central & South America mRNA Vaccines Market Size by Type (2015-2020)
    12.4 Central & South America mRNA Vaccines Market Size by Application (2015-2020)

13Key Players Profiles
    13.1 MODERNA
        13.1.1 MODERNA Company Details
        13.1.2 MODERNA Business Overview and Its Total Revenue
        13.1.3 MODERNA mRNA Vaccines Introduction
        13.1.4 MODERNA Revenue in mRNA Vaccines Business (2019-2020))
        13.1.5 MODERNA Recent Development
    13.2 Pfizer
        13.2.1 Pfizer Company Details
        13.2.2 Pfizer Business Overview and Its Total Revenue
        13.2.3 Pfizer mRNA Vaccines Introduction
        13.2.4 Pfizer Revenue in mRNA Vaccines Business (2019-2020))
        13.2.5 Pfizer Recent Development
    13.3 Zydus Cadila
        13.3.1 Zydus Cadila Company Details
        13.3.2 Zydus Cadila Business Overview and Its Total Revenue
        13.3.3 Zydus Cadila mRNA Vaccines Introduction
        13.3.4 Zydus Cadila Revenue in mRNA Vaccines Business (2019-2020))
        13.3.5 Zydus Cadila Recent Development
    13.4 Fosun Pharmaceutical
        13.4.1 Fosun Pharmaceutical Company Details
        13.4.2 Fosun Pharmaceutical Business Overview and Its Total Revenue
        13.4.3 Fosun Pharmaceutical mRNA Vaccines Introduction
        13.4.4 Fosun Pharmaceutical Revenue in mRNA Vaccines Business (2019-2020))
        13.4.5 Fosun Pharmaceutical Recent Development
    13.5 CureVac
        13.5.1 CureVac Company Details
        13.5.2 CureVac Business Overview and Its Total Revenue
        13.5.3 CureVac mRNA Vaccines Introduction
        13.5.4 CureVac Revenue in mRNA Vaccines Business (2019-2020))
        13.5.5 CureVac Recent Development
    13.6 Stemirna
        13.6.1 Stemirna Company Details
        13.6.2 Stemirna Business Overview and Its Total Revenue
        13.6.3 Stemirna mRNA Vaccines Introduction
        13.6.4 Stemirna Revenue in mRNA Vaccines Business (2019-2020))
        13.6.5 Stemirna Recent Development

14 Market Dynamics
    14.1 Drivers
    14.2 Challenges
    14.3 Porter’s Five Forces Analysis
    14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables Table 1. mRNA Vaccines Key Market Segments Table 2. Key Players Covered: Ranking by mRNA Vaccines Revenue Table 3. Ranking of Global Top mRNA Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Being Developed Table 6. Key Players of Preclinical Table 7. Key Players of Clinical I Table 8. Key Players of Clinical II Table 9. COVID-19 Impact Global Market: (Four mRNA Vaccines Market Size Forecast Scenarios) Table 10. Opportunities and Trends for mRNA Vaccines Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for mRNA Vaccines Players to Combat Covid-19 Impact Table 14. Global mRNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026 Table 17. Global mRNA Vaccines Market Share by Regions 2019-2026 Table 18. Market Top Trends Table 19. Market Use Cases Table 20. Global mRNA Vaccines Revenue by Players (2019-2020) (Million US$) Table 21. Global mRNA Vaccines Market Share by Players (2019-2020) Table 22. Key Players Headquarters and Area Served Table 23. Key Players mRNA Vaccines Product Solution and Service Table 24. Date of Enter into mRNA Vaccines Market Table 25. Global Key Players mRNA Vaccines Funding/Investment Analysis (Million USD) Table 26. Global Key Players mRNA Vaccines Valuation & Market Capitalization (Million USD) Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 29. Global mRNA Vaccines Market Size Share by Type (2019-2026) Table 30. Global mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 31. Global mRNA Vaccines Market Size Share by Application (2019-2026) Table 32. North America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 33. North America Key Players mRNA Vaccines Market Share (2019-2020) Table 34. North America mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 35. North America mRNA Vaccines Market Share by Type (2019-2026) Table 36. North America mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 37. North America mRNA Vaccines Market Share by Application (2019-2026) Table 38. Europe Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 39. Europe Key Players mRNA Vaccines Market Share (2019-2020) Table 40. Europe mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 41. Europe mRNA Vaccines Market Share by Type (2019-2026) Table 42. Europe mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 43. Europe mRNA Vaccines Market Share by Application (2019-2026) Table 44. China Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 45. China Key Players mRNA Vaccines Market Share (2019-2020) Table 46. China mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 47. China mRNA Vaccines Market Share by Type (2019-2026) Table 48. China mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 49. China mRNA Vaccines Market Share by Application (2019-2026) Table 50. Japan Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 51. Japan Key Players mRNA Vaccines Market Share (2019-2020) Table 52. Japan mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 53. Japan mRNA Vaccines Market Share by Type (2019-2026) Table 54. Japan mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 55. Japan mRNA Vaccines Market Share by Application (2019-2026) Table 56. Southeast Asia Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players mRNA Vaccines Market Share (2019-2020) Table 58. Southeast Asia mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 59. Southeast Asia mRNA Vaccines Market Share by Type (2019-2026) Table 60. Southeast Asia mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 61. Southeast Asia mRNA Vaccines Market Share by Application (2019-2026) Table 62. India Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 63. India Key Players mRNA Vaccines Market Share (2019-2020) Table 64. India mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 65. India mRNA Vaccines Market Share by Type (2019-2026) Table 66. India mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 67. India mRNA Vaccines Market Share by Application (2019-2026) Table 68. Central & South America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players mRNA Vaccines Market Share (2019-2020) Table 70. Central & South America mRNA Vaccines Market Size by Type (2019-2026) (Million US$) Table 71. Central & South America mRNA Vaccines Market Share by Type (2019-2026) Table 72. Central & South America mRNA Vaccines Market Size by Application (2019-2026) (Million US$) Table 73. Central & South America mRNA Vaccines Market Share by Application (2019-2026) Table 74. MODERNA Company Details Table 75. MODERNA Business Overview Table 76. MODERNA Product Table 77. Company Description and Business Overview Table 78. MODERNA mRNA Vaccines Product Table 79. MODERNA Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 80. MODERNA Recent Development Table 81. Pfizer Company Details Table 82. Pfizer Business Overview Table 83. Pfizer Product Table 84. Company Description and Business Overview Table 85. Pfizer mRNA Vaccines Product Table 86. Pfizer Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 87. Pfizer Recent Development Table 88. Zydus Cadila Company Details Table 89. Zydus Cadila Business Overview Table 90. Zydus Cadila Product Table 91. Company Description and Business Overview Table 92. Zydus Cadila mRNA Vaccines Product Table 93. Zydus Cadila Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 94. Zydus Cadila Recent Development Table 95. Fosun Pharmaceutical Company Details Table 96. Fosun Pharmaceutical Business Overview Table 97. Fosun Pharmaceutical Product Table 98. Company Description and Business Overview Table 99. Fosun Pharmaceutical mRNA Vaccines Product Table 100. Fosun Pharmaceutical Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 101. Fosun Pharmaceutical Recent Development Table 102. CureVac Company Details Table 103. CureVac Business Overview Table 104. CureVac Product Table 105. Company Description and Business Overview Table 106. CureVac mRNA Vaccines Product Table 107. CureVac Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 108. CureVac Recent Development Table 109. Stemirna Company Details Table 110. Stemirna Business Overview Table 111. Stemirna Product Table 112. Company Description and Business Overview Table 113. Stemirna mRNA Vaccines Product Table 114. Stemirna Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$) Table 115. Stemirna Recent Development Table 116. Company Description and Business Overview Table 117. Company Description and Business Overview Table 118. Company Description and Business Overview Table 119. Company Description and Business Overview Table 120. Company Description and Business Overview Table 121. Company Description and Business Overview Table 122. Company Description and Business Overview Table 123. Company Description and Business Overview Table 124. Company Description and Business Overview Table 125. Company Description and Business Overview Table 126. Company Description and Business Overview Table 127. Company Description and Business Overview Table 128. Company Description and Business Overview Table 129. Company Description and Business Overview Table 130. Company Description and Business Overview Table 131. Company Description and Business Overview Table 132. Company Description and Business Overview Table 133. Company Description and Business Overview Table 134. Company Description and Business Overview Table 135. Company Description and Business Overview Table 136. Company Description and Business Overview Table 137. Company Description and Business Overview Table 138. Company Description and Business Overview Table 139. Company Description and Business Overview Table 140. Company Description and Business Overview Table 141. Company Description and Business Overview Table 142. Company Description and Business Overview Table 143. Company Description and Business Overview Table 144. Company Description and Business Overview Table 145. Company Description and Business Overview Table 146. Company Description and Business Overview Table 147. Company Description and Business Overview Table 148. Company Description and Business Overview Table 149. Company Description and Business Overview Table 150. Key Drivers: Impact Analysis (2021-2026) Table 151. Key Opportunities Table 152. Key Challenges Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Global mRNA Vaccines Market Share by Type: 2020 VS 2026 Figure 2. Being Developed Features Figure 3. Preclinical Features Figure 4. Clinical I Features Figure 5. Clinical II Features Figure 6. Global mRNA Vaccines Market Share by Application: 2020 VS 2026 Figure 7. COVID-19 Case Studies Figure 8. Cancer Case Studies Figure 9. Infectious Disease Treatment MRNA Vaccine Case Studies Figure 10. Infection Prevention MRNA Vaccine Case Studies Figure 11. mRNA Vaccines Report Years Considered Figure 12. Global mRNA Vaccines and Growth Rate (2019-2026) (Million US$) Figure 13. Global mRNA Vaccines Market Share by Regions (2019-2026) Figure 14. Global mRNA Vaccines Market Share by Players in 2019 Figure 15. Global mRNA Vaccines Market Size Market Share by Type (2019-2026) Figure 16. Global mRNA Vaccines Market Size Market Share by Application (2019-2026) Figure 17. North America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 18. Europe mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 19. China mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 20. Japan mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 21. Southeast Asia mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 22. India mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 23. Central & South America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$) Figure 24. Bottom-up and Top-down Approaches for This Report Figure 25. Data Triangulation Figure 26. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Media and Technology Reports

Global COVID-19 IgG/IgM Rapid Test Cassette Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The COVID-19 IgG/IgM Rapid Test Cassette market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impac...

Global COVID-19 Rapid Test Kits Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The COVID-19 Rapid Test Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domesti...

Global Insurance for Recovery Work in Covid-19 Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Insurance for Against Covid-19 Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Microwave Energy Fuel Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Other Reports by QY Research

Global Soft Gelatin Capsules (Softgels) Market Professional Survey Report 2020

In 2019, the global softgel capsules market size was US$ 3824 million and it is expected to reach US$ 5405 million by the end of 2026, with a CAGR of 5.3% between 2020 and 2026. This report focuses on Soft Gelatin Capsules (Softgels) volume and value...

Global Pressure Vessel Composite Materials Market Report, History and Forecast 2015-2026

Market Analysis and Insights: Global Pressure Vessel Composite Materials Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a publ...

Global PNH and aHUS Market Size, Status and Forecast 2020-2026

Market Analysis and Insights: Global PNH and aHUS Market Due to COVID-19, the market for PNH and aHUS was anticipated to grow from US$ 4855 million in 2020 to US$ 7023 million by 2026; it is expected to grow at a CAGR of 5.89% during 2021 2026. Glob...

Global Nonwoven Fabrics for Filtration Market Research Report 2020

Market Analysis and Insights: Global Nonwoven Fabrics for Filtration Market The global Nonwoven Fabrics for Filtration market is valued at USD 6174 million in 2020 and is expected to reach USD 5180 million by the end of 2027, growing at a CAGR of -2....

Global Mechanical Chest Compression Devices Market Report 2020

Market Analysis and Insights: Global Mechanical Chest Compression Devices Market The global Mechanical Chest Compression Devices market was US$ 158.43 million in 2019 and is expected to US$ 271.07 million by the end of 2026, growing at a CAGR of 6.55...

Publisher: QY Research
Chat with us